Patients with chemorefractory metastatic colorectal cancer derive no overall survival benefit from giving anti-EGFR ...
Government agreement with IVF drug manufacturer drops price in exchange for tariff reductions, expedited FDA approval ...
MedPage Today on MSN
Novel T-Cell Therapy Promising in Tough-to-Treat Eye Cancer
Among 16 patients with this difficult-to-treat tumor "with few treatment options," the confirmed overall response rate (ORR) ...
KTVU FOX 2 San Francisco on MSN
Trump announces deal to cut IVF drug prices in exchange for tariff relief
President Donald Trump on Friday announced a deal with pharmaceutical company Merck and its U.S. subsidiary, EMD Serono, to ...
MedPage Today on MSN
A Hit and a Miss for Liquid Biopsy to Guide Adjuvant Cancer Therapy
Median disease-free survival (DFS) increased from 4.8 months with placebo to 9.9 months with adjuvant atezolizumab (Tecentriq ...
GlobalData on MSN
EMD Serono partners US government to widen IVF access
Merck’s healthcare division in Canada and the US, EMD Serono, has signed an agreement with the Trump administration to expand ...
Fertility drugmaker EMD Serono, the U.S. arm of Merck KGaA, will offer its in vitro fertilization (IVF) treatments at a sharp discount on the government's DTC platform TrumpRx.
As a newly christened manufacturing facility comes online in one part of Ireland, Merck KGaA plans to turn out the lights at ...
EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, and President Donald J.
Merck KGaA has become the third pharma company to reach an agreement with the Trump administration to cut the cost of some of ...
U.S. President Donald Trump and Germany's Merck KGaA on Thursday said they had struck a deal that would cut the cost of some ...
EMD Serono will sell fertility drugs on the Trump direct-to-consumer marketplace. Trump also preview plans to encourage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results